The effect of photodynamic therapy on the microcirculation.

Photodynamic therapy (PDT) is a new form of cancer therapy involving tumor localization by photosensitizing drugs such as dihematoporphyrin ether (DHE). Light irradiation of drug-sensitized tissue results in photoactivation of DHE and tumor necrosis. The mechanism of action is incompletely understood but involves the generation of singlet oxygen which produces cytotoxic effects on tissues containing the compound. In addition, microcirculatory aberrations have been described during PDT. We have studied the acute effects of PDT on the microcirculation using in vivo television microscopy of the rat cremaster. This has enabled us to observe the effects of PDT on both paired and unpaired arterioles and venules using two different wavelengths of activating light (blue, 450-490 nm, and green, 530-560 nm). For both wavelengths of activating light, significant reduction in blood flow of all vessels was seen during PDT. This, in combination with the formation and embolization of platelet thrombi, resulted in stasis of blood flow in 80% of arterioles and 90% of venules. Observation for 2 hr after the completion of photoactivation revealed reperfusion in 20% of the arterioles but none of the venules. Blood flow was reduced by a combination of vasoconstriction and platelet thrombus formation. Reducing the total activating energy from 120J/cm2 to 24J/cm2 significantly reduced the response in venules and the incidence of stasis in both arterioles and venules. We conclude that the photoactivation of DHE results in significant vasoconstriction and thrombosis of normal vessels and that if these effects are seen at later times after DHE administration and in tumor neovasculature they may contribute to the mechanism by which PDT results in tumor necrosis.

[1]  J. Vane,et al.  A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation. , 1976, Prostaglandins.

[2]  A CASTELLANI,et al.  Photodynamic effect of haematoporphyrin on blood microcirculation. , 1963, The Journal of pathology and bacteriology.

[3]  Finney Dj,et al.  Field sampling for the estimation of wireworm populations. , 1946 .

[4]  S. Britton,et al.  Blood flow in transplantable bladder tumors treated with hematoporphyrin derivative and light. , 1984, Cancer research.

[5]  R. Keck,et al.  Jejunal blood flow after exposure to light in rats injected with hematoporphyrin derivative. , 1985, Cancer research.

[6]  J Moan,et al.  Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. , 1985, Cancer research.

[7]  L. Dubertret,et al.  A MICROSPECTROFLUOROMETRIC STUDY OF PORPHYRIN‐PHOTOSENSITIZED SINGLE LIVING CELLS— I. MEMBRANE ALTERATIONS , 1986, Photochemistry and photobiology.

[8]  G. H. Gijsbers,et al.  Wavelength and light-dose dependence in tumour phototherapy with haematoporphyrin derivative. , 1985, British Journal of Cancer.

[9]  W. Star,et al.  Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. , 1986, Cancer research.

[10]  C. Gomer,et al.  Expression of potentially lethal damage in Chinese hamster cells exposed to hematoporphyrin derivative photodynamic therapy. , 1986, Cancer research.

[11]  D. B. Duncan MULTIPLE RANGE AND MULTIPLE F TESTS , 1955 .

[12]  T J Dougherty,et al.  Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. , 1976, Cancer research.

[13]  S. Britton,et al.  Morphologic studies of bladder tumors treated with hematoporphyrin derivative photochemotherapy. , 1985, The American journal of pathology.

[14]  B. Ward,et al.  The treatment of vaginal recurrences of gynecologic malignancy with phototherapy following hematoporphyrin derivative pretreatment. , 1982, American journal of obstetrics and gynecology.

[15]  M. J. Gemert,et al.  Haematoporphyrin-derivative fluorescence in vitro and in an animal tumour. , 1983 .

[16]  G. Murphy,et al.  Superficial bladder tumor. Aspects of clinical progression. , 1974, Urology.

[17]  R. Guy,et al.  LASER DOPPLER VELOCIMETRY TO QUANTIFY UV‐B INDUCED INCREASE IN HUMAN SKIN BLOOD FLOW , 1985, Photochemistry and photobiology.

[18]  I. Gigli,et al.  Participation of mast cells and complement in the immediate phase of hematoporphyrin-induced phototoxicity. , 1984, The Journal of investigative dermatology.

[19]  T. Dougherty,et al.  Photoradiation therapy in advanced carcinoma of the trachea and bronchus. , 1984, Chest.

[20]  M. Berns,et al.  Laser photoradiation therapy of cancer following hematoporphyrin sensitization , 1982, Lasers in surgery and medicine.